SCHEMBL7532840

SCHEMBL7532840

C=CN(C)CCCCCCCCCCCCCCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 4/20 0.52
TSHR P16473 4/20 0.44
THRB P10828 1/20 0.40
ZDHHC20 Q5W0Z9 1/20 0.38
ZDHHC2 Q9UIJ5 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
S1PR2 O95136 1/20 0.36
S1PR1 P21453 1/20 0.36
S1PR3 Q99500 1/20 0.36
S1PR5 Q9H228 1/20 0.36
ADH1C P00326 1/20 0.36
ADH1A P07327 1/20 0.36
ADH4 P08319 1/20 0.36
ALDH1A1 P00352 2/20 0.36
FAAH O00519 1/20 0.35
GBA1 P04062 1/20 0.34
GGPS1 O95749 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7534338 1.00 DNM1 (0.52) DNM1TSHRTHRBZDHHC20ZDHHC2
SCHEMBL7535572 1.00 DNM1 (0.52) DNM1TSHRTHRBZDHHC20ZDHHC2
SCHEMBL7540740 1.00 DNM1 (0.52) DNM1TSHRTHRBZDHHC20ZDHHC2
SCHEMBL7534144 1.00 DNM1 (0.52) DNM1TSHRTHRBZDHHC20ZDHHC2
SCHEMBL7534949 1.00 DNM1 (0.52) DNM1TSHRTHRBZDHHC20ZDHHC2
SCHEMBL7534367 1.00 DNM1 (0.52) DNM1TSHRTHRBZDHHC20ZDHHC2
SCHEMBL7535055 1.00 DNM1 (0.52) DNM1TSHRTHRBZDHHC20ZDHHC2
SCHEMBL7539593 1.00 DNM1 (0.52) DNM1TSHRTHRBZDHHC20ZDHHC2
SCHEMBL7539640 1.00 DNM1 (0.52) DNM1TSHRTHRBZDHHC20ZDHHC2
SCHEMBL7535484 1.00 DNM1 (0.52) DNM1TSHRTHRBZDHHC20ZDHHC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1223161-A2 Method to stabilise and/or lower the color number of alkenyl compounds BASF AKTIENGESELLSCHAFT (DE) 2002-07-17 EP disclosed
US-20020091254-A1 Stabilizing and/or lowering the color number of alkenyl compounds BASF AKTIENGESELLSCHAFT (DE) 2002-07-11 US disclosed
US-6384216-B1 CARRYING OUT TWO DISTILLATIONS IN WHICH THE PURIFIED ALKENYL COMPOUNDS OBTAINED FROM GAS PHASE BY CONDENSATION, WHERE THE TIME BETWEEN FIRST DISTILLATION AFTER SYNTHESIS OF ALKENYL COMPOUNDS AND FURTHER DISTILLATION BASF AKTIENGESELLSCHAFT (DE) 2002-05-07 US disclosed
US-20020038059-A1 PURIFICATION OF ALKENYL COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2002-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091254-A1 Stabilizing and/or lowering the color number of alkenyl compounds SOD1, NOX4, CAT DNM1 2066/4885TSHR 4454/4885THRB 4174/4885
US-20020038059-A1 PURIFICATION OF ALKENYL COMPOUNDS TPR, AGPAT5, PCNA DNM1 4210/4885TSHR 3704/4885THRB 2904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.